Business ❯ Pharmaceuticals

Generic Drugs

Market Competition Market Launch Manufacturing Market Dynamics International Trade Trade Policies Market Impact Market Trends Import Tariffs Cancer Treatment

Sandoz Agrees to $478.5 Million in U.S. Settlements Over Generic Drug Pricing

The deals narrow the company’s U.S. exposure to mainly individual plaintiffs who opted out of class cases.

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

Apotex Files for Up to C$1.2 Billion Toronto IPO

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

Multiple Indian Drugmakers Win U.S. Clearance to Sell Farxiga Generic

Emcure Slashes Price of Novo’s Semaglutide Brand Poviztra by Up to 55% in India

Delhi High Court Allows Zydus to Market Nivolumab Biosimilar on Public‑Interest Grounds

Servier Enters Exclusive Talks With BC Partners Over €800M–€1B Sale of Biogaran

Wockhardt Liquidates US Generics Units to Fuel Antibiotic and Insulin Innovation

Mallinckrodt and Endo to Merge in $6.7 Billion Deal